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Nancy Langston examines the history of syn-
thetic chemicals that disrupt hormones in our 
bodies and the ecosystem, and the struggles 
government agencies have faced in regulat-
ing them. She uses the powerful case study 
of the synthetic estrogen diethylstilbestrol 
(DES) as an example of what can go wrong 
if precautionary measures are not followed 
in protecting public health. Although DES was 
ultimately prescribed for use in all pregnancies to ensure 
bigger, healthier babies, there was no science that supported safe use 
in normal pregnancy. She helps answer the question of why DES was 
so widely used in the face of conflicting evidence over its efficacy and 
safety. Langston presents a well-documented historical account of DES 
and parallels its story with the indiscriminate use of numerous other 
endocrine-disrupting chemicals today. She points out the disturbing 
possibility of a repeat of the DES scenario.
DES was first synthesized in 1938 by British biochemist Sir 
Edward Charles Dodds who, along with colleagues, searched for 
synthetic estrogens that could be easily and inexpensively made to 
treat symptoms of menopause, termed a “deficiency disease” by the 
medical profession. By 1941, DES was found in almost every aspect of 
American life, although researchers knew that it caused cancer and sex-
ual dysfunction in experimental animals and their offspring. Not only 
was it widely prescribed as hormone replacement therapy, it was also 
given to pregnant women at risk for miscarriage. DES became so popu-
lar that it was prescribed for normal healthy pregnancies much like vita-
min pills, although it was never demonstrated to have beneficial effects, 
and many women were never informed they were given the drug. DES 
was also used to treat numerous other medical conditions including 
breast and prostate cancer, stop production of milk after childbirth for 
non-nursing women, treat menstrual disorders, treat acne, and halt the 
growth of young girls considered at risk for getting too tall. In addition, 
DES was quickly introduced into veterinary practice to treat infertility 
and mastitis in livestock, as pellets implanted into poultry and livestock 
and as feed additives for cattle to improve feed efficiency and promote 
rapid weight gain. Langston cites a report stating that, by 1955, > 90% 
of the livestock in this country was being given DES. 
Today we know the harmful effects of DES, especially if exposure 
occurs during prenatal development; at pharmaceutical levels, there is 
a low but significant increase (< 0.01%) in cancer in young women 
who were exposed before birth, and there is a high incidence (> 90%) 
of non-cancer reproductive abnormalities in both male and female 
offspring. The full extent of DES’s adverse effects remains to be deter-
mined as the exposed population ages, but it may involve additional 
generations (DES grandchildren). Describing low levels of DES expo-
sure such as those obtained from eating meat, Langston compellingly 
argues that DES and other chemical residues are playing a role in cur-
rent health problems such as increased infertility and cancer rates.
Almost immediately after its introduction to the public, DES 
posed problems for regulatory agencies charged with protecting public 
health while not stifling the marketing of beneficial drugs. DES came 
before the Food and Drug Administration (FDA) three different times, 
and despite the agency’s concern for safety, it backed way from regula-
tory actions due to strong political pressure from the pharmaceutical 
and agricultural communities. Langston does not fault FDA or other 
government scientists for failure to act, but rather points to many dedi-
cated investigators and concerned politicians who worked in the past to 
protect human health. She does, however, unapologetically name some 
early government administrators, politicians, and industry representa-
tives who, as she states, “chose the health of big business over public 
good, and . . . skillfully manipulated scientific uncertainty to delay regu-
lation.” She points out that the old FDA mind-set to protect industry 
and promote the economy is still entrenched in the FDA today. 
As an environmental historian, Langston sees a similar pattern 
in the lack of regulation between DES in the past and endocrine-
disrupting chemicals such as bisphenol A today. The purpose of 
Langston’s book is to point out how lessons from history can be used 
to make better policy, as well as “the need for intelligent regulation 
to protect public health and the environment.” She challenges read-
ers to stay informed, take action, and support government agencies 
in their struggle in applying the precautionary principle to protect 
human health. She convincingly advocates that public health concerns 
should take precedence over short-term economic gains in the face of 
  scientific uncertainty.
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